ホーム › 乳がん › メリーランド州 › Columbia
Columbia、MDにおける乳がんの臨床試験
Columbiaとその周辺地域（約30マイル以内）の拠点で、乳がんに関する15件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
被験者募集中第3相
- Maryland Oncology Hematology P.A., Columbia
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
被験者募集中観察研究健康なボランティア歓迎
- Northwest Hospital Center, Randallstown · 9マイル先
- William E Kahlert Regional Cancer Center/Sinai Hospital, Westminster · 25マイル先
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
被験者募集中第2相
- Maryland Oncology Hematology, Laurel · 10マイル先
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
被験者募集中第3相
- Research Site, Columbia
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
被験者募集中第3相
- Clinical Trial Site, Catonsville · 6マイル先
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
被験者募集中第3相
- Maryland Oncology Hematology, P.A., Columbia
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
被験者募集中第3相
- Northwest Hospital Center, Randallstown · 9マイル先
E-Mindfulness Approaches for Living After Breast Cancer
被験者募集中第3相
- Central Maryland Radiation Oncology in Howard County, Columbia
Integrated Cancer Repository for Cancer Research
被験者募集中観察研究健康なボランティア歓迎
- Northwest Hospital, Randallstown · 9マイル先
- William E. Kahlert Regional Cancer Center, Westminster · 25マイル先
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
被験者募集中第3相
- Maryland Oncology Hematology P.A., Columbia
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
被験者募集中第3相
- Central Maryland Radiation Oncology in Howard County, Columbia
Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer
被験者募集中第2相
- Maryland Oncology Hematology, Columbia
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
被験者募集中観察研究
- William E Kahlert Regional Cancer Center/Sinai Hospital, Westminster · 25マイル先
GammaPod Dose Escalation Radiation for Early Stage Breast Cancer
被験者募集中
- Central Maryland Oncology Center, Columbia
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
被験者募集中観察研究
- Maryland Oncology Hematology, PA, Columbia
他の都市における乳がんの試験
- New York City, NY137件の研究
- Houston, TX127件の研究
- Boston, MA113件の研究
- Nashville, TN80件の研究
- Los Angeles, CA72件の研究
- Edison, NJ67件の研究
- St. Louis, MO65件の研究
- Durham, NC64件の研究
- Queens, NY63件の研究
- Chicago, IL59件の研究
- Philadelphia, PA57件の研究
- Dallas, TX56件の研究
Columbiaにおける他の研究
- 肺がん7件の研究
- 前立腺がん6件の研究
- 非小細胞肺癌6件の研究
- 膀胱癌5件の研究
- 転移性癌5件の研究
- 大腸癌5件の研究
- 悪性黒色腫4件の研究
- 結腸癌4件の研究
- 膵臓がん4件の研究
- 過体重4件の研究
- 心血管疾患3件の研究
- 2型糖尿病3件の研究
ClinicalTrials.govより、2026/10/07時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。